- Home
- ยป
- Our Products
- »
- Pharmaceutical Injections
Pharmaceutical Injections
Enoxaparin Injection(Evaparin 300mg Injection)
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 300mg/3ml |
| Packaging Type | Single use syringe |
| Brand | Evaparin |
| Packaging Size | 3 ml in 1 cartridge |
| Composition | Enoxaparin 300mg |
| Brand Name | Evaparin |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usages | Treatment and prevention of Blood clots |
| Dose | 300 mg/3 ml |
Enoxaparin Injection (Evaparin 300 mg Injection)
Indications:Enoxaparin is indicated for:
- Prophylaxis of deep vein thrombosis (DVT) in patients undergoing surgery or immobilization.
- Treatment of DVT and pulmonary embolism (PE).
- Prevention of thrombus formation in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
- Adjunct therapy in ST elevation myocardial infarction (STEMI) in conjunction with percutaneous coronary intervention (PCI).
Enoxaparin is a low molecular weight heparin (LMWH) that inhibits factor Xa and factor IIa (thrombin) in the coagulation cascade. This anticoagulant effect helps prevent the formation and growth of blood clots.
Dosage and Administration:- Dosage: The typical dosage for prophylaxis of DVT is 40 mg subcutaneously once daily, while treatment of DVT or PE may require 1 mg/kg subcutaneously every 12 hours or 1.5 mg/kg once daily, depending on the clinical scenario.
- Administration: Administered via subcutaneous injection in the abdomen or thigh. Rotate injection sites to minimize irritation.
- Hypersensitivity to enoxaparin or any component of the formulation.
- Active major bleeding or a history of heparin-induced thrombocytopenia (HIT).
- Severe renal impairment (creatinine clearance <30 mL/min).
- Bleeding Risk: Increased risk of bleeding; monitor for signs of bleeding, especially in patients with concurrent anticoagulant therapy.
- Renal Function: Use with caution in patients with renal impairment, as dosage adjustments may be necessary.
- Spinal or Epidural Anesthesia: Caution in patients undergoing procedures involving spinal or epidural anesthesia due to the risk of hematoma.
Common side effects:
- Injection site reactions (pain, bruising, hematoma)
- Nausea
- Mild elevation of liver enzymes
Serious side effects:
- Severe bleeding
- Thrombocytopenia (low platelet count)
- Allergic reactions (anaphylaxis)
Enoxaparin may interact with other anticoagulants, antiplatelet agents, and NSAIDs. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection techniques and the importance of rotating injection sites.
- Advise patients to report any signs of unusual bleeding or bruising.
- Discuss the importance of regular follow-up appointments for monitoring.
Enoxaparin Injection (Evaparin 300 mg) is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Close monitoring and communication with healthcare providers are essential for optimizing treatment outcomes and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Leugard 22.5mg Injection
Product Brochure
| Strength | 22.5 mg |
| Brand | Leugard |
| Manufacturer | Zydus Cadila |
| Packaging Size | 1*1 |
| Treatment | Prostate cancer |
Luprova 22.5 mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 22.5 mg |
| Pack Size | 1 Injection in 1 Vial |
| Composition | Leuprolide 22.5 mg |
| Brand Name | Luprova |
| Manufacturer | Celon Laboratories Ltd |
| Treatment | Prostate cancer, Breast cancer, Endometriosis, Precocious puberty |
Luprova 22.5 mg Injection
Overview:
Luprova (Leuprorelin acetate) 22.5 mg is a long-acting gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-sensitive conditions, including prostate cancer, endometriosis, uterine fibroids, and precocious puberty. It works by suppressing the production of sex hormones (testosterone and estrogen), which helps to manage conditions driven by these hormones.
Indications:
Luprova 22.5 mg is indicated for:
- Prostate Cancer: Used in advanced prostate cancer to reduce testosterone levels and slow cancer progression.
- Endometriosis: To reduce pain and prevent the growth of endometrial tissue.
- Uterine Fibroids: To shrink fibroids and alleviate symptoms like heavy bleeding and pelvic pain.
- Precocious Puberty: To delay early puberty in children by suppressing premature sex hormone release.
Mechanism of Action:
Luprova is a GnRH agonist that initially stimulates the pituitary gland, causing a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Over time, it desensitizes the pituitary gland, leading to a dramatic decrease in LH and FSH production. This results in reduced production of testosterone in men and estrogen in women, effectively controlling hormone-driven conditions.
Dosage and Administration:
- Recommended Dose: Luprova 22.5 mg is typically administered as an intramuscular injection every 3 months for prostate cancer, endometriosis, and uterine fibroids. For precocious puberty, dosing may be adjusted based on the patient’s weight and specific needs.
- Administration: The injection is given intramuscularly, typically by a healthcare professional. It can be provided as a prefilled syringe or reconstituted before injection.
Side Effects:
- Common Side Effects: Hot flashes, fatigue, headache, nausea, and injection site reactions.
- Serious Side Effects: Osteoporosis, cardiovascular risks, mood changes, and liver dysfunction.
- Long-Term Risks: Extended use may lead to bone thinning, requiring monitoring for signs of osteoporosis.
Precautions:
- Bone Health: Monitor bone density during long-term treatment.
- Pregnancy and Breastfeeding: Contraindicated during pregnancy and breastfeeding.
- Heart Disease: Use cautiously in patients with cardiovascular risk factors.
Storage:
Store at room temperature (15°C to 30°C), away from light, and out of reach of children.
Conclusion:
Luprova 22.5 mg injection is a crucial treatment for hormone-sensitive conditions like prostate cancer, endometriosis, and uterine fibroids, suppressing sex hormones to control disease progression. Regular monitoring for side effects, particularly bone health, is essential for safe use.
Enoxaparin Sodium 40 Mg Injection (LONOPIN 40mg Injection )
Minimum Order Quantity: 10 Box
Product Brochure
| Strength | 40 mg |
| Pack Size | 0.4 ml |
| Pack Type | Box |
| Composition | Enoxaparin 40mg |
| Brand Name | Lonopin |
| Manufacturer | Bharat Serums & Vaccines Ltd |
| Usages | Treatment and prevention of Blood clots |
| Prescription/ Non Prescription | Non Prescription |
| Country of Origin | Made in India |
Enoxaparin Sodium 40 mg Injection (Lonopin 40 mg Injection)
Indications: Lonopin (Enoxaparin Sodium) is primarily indicated for:
- Prevention of Deep Vein Thrombosis (DVT): Especially in patients undergoing surgery (e.g., hip or knee replacement) or those at high risk for thromboembolic events.
- Treatment of DVT and Pulmonary Embolism (PE): As part of a comprehensive treatment regimen.
- Acute Coronary Syndrome (ACS): To reduce the risk of myocardial infarction in high-risk patients.
Mechanism of Action: Enoxaparin is a low molecular weight heparin (LMWH) that acts by:
- Inhibiting factor Xa and, to a lesser extent, factor IIa (thrombin) in the coagulation cascade.
- Preventing the formation of blood clots and facilitating the breakdown of existing clots.
Dosage and Administration:
- Dosage: For DVT prevention, the usual dose is 40 mg administered once daily. For treatment or other indications, dosing may vary based on clinical guidelines and individual patient needs.
- Administration: Administered via subcutaneous injection, typically in the abdominal area. Rotate injection sites to minimize irritation.
Contraindications:
- Hypersensitivity to enoxaparin or any component of the formulation.
- Active bleeding or conditions that significantly increase the risk of bleeding (e.g., recent surgery, trauma).
- Severe renal impairment (creatinine clearance <30 mL/min).
Warnings and Precautions:
- Bleeding Risk: Increased risk of bleeding; monitor for signs of unusual bleeding or bruising.
- Thrombocytopenia: Regular monitoring of platelet counts is advised, particularly in patients with a history of heparin-induced thrombocytopenia.
- Renal Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
Side Effects:
- Common: Injection site reactions (pain, redness, swelling), nausea, and mild fever.
- Serious: Severe bleeding, thrombocytopenia, and allergic reactions (rare).
Drug Interactions: Enoxaparin may interact with other anticoagulants, antiplatelet agents, and medications that affect bleeding risk. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Instruct patients on proper injection techniques and the importance of rotating injection sites.
- Advise patients to report any signs of unusual bleeding, bruising, or other concerning symptoms.
- Discuss the importance of regular follow-up appointments for monitoring.
Conclusion: Lonopin (Enoxaparin Sodium) 40 mg Injection is an effective anticoagulant for preventing and treating thromboembolic disorders. Close monitoring and communication with healthcare providers are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Enoxaparin Injection (Lomocare 40mg Injection)
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 40 mg |
| Pack Size | 0.4 ml |
| Composition | Enoxaparin 40mg |
| Brand Name | Lomocare |
| Manufacturer | Gufic Bioscience Ltd |
| Usages | Treatment and counteraction of Blood clusters |
| Country of Origin | Made in India |
Enoxaparin Injection (Lomocare 40 mg Injection)
Indications: Lomocare (Enoxaparin) is primarily indicated for:
- Deep Vein Thrombosis (DVT) Prevention: Especially in patients undergoing surgery or those at high risk for thromboembolic events.
- Treatment of DVT and Pulmonary Embolism (PE): As part of a comprehensive treatment plan.
- Acute Coronary Syndrome (ACS): To reduce the risk of myocardial infarction and other cardiovascular events.
Mechanism of Action: Enoxaparin is a low molecular weight heparin (LMWH) that works by:
- Inhibiting factor Xa and, to a lesser extent, factor IIa (thrombin) in the coagulation cascade.
- Preventing the formation of clots and promoting the breakdown of existing clots, thus reducing the risk of thromboembolic events.
Dosage and Administration:
- Dosage: For DVT prevention, the typical dose is 40 mg once daily. For treatment of DVT/PE or ACS, doses may vary and should be determined by a healthcare provider.
- Administration: Administered via subcutaneous injection, typically in the abdominal area. Rotate injection sites to minimize irritation.
Contraindications:
- Hypersensitivity to enoxaparin or any component of the formulation.
- Active bleeding or conditions that significantly increase the risk of bleeding (e.g., recent surgery, trauma).
- Severe renal impairment (creatinine clearance <30 mL/min).
Warnings and Precautions:
- Bleeding Risk: Increased risk of bleeding; monitor for signs of unusual bleeding or bruising.
- Thrombocytopenia: Monitor platelet counts regularly, especially in patients with a history of heparin-induced thrombocytopenia.
- Renal Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
Side Effects:
- Common: Injection site reactions (pain, redness, swelling), nausea, and mild fever.
- Serious: Severe bleeding, thrombocytopenia, and allergic reactions.
Drug Interactions: Enoxaparin may interact with other anticoagulants, antiplatelet agents, and medications affecting bleeding risk. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Instruct patients on proper injection techniques and the importance of rotating injection sites.
- Advise patients to report any signs of unusual bleeding, bruising, or other concerning symptoms.
- Discuss the importance of regular follow-up appointments for monitoring.
Conclusion: Lomocare (Enoxaparin) 40 mg Injection is an effective anticoagulant for the prevention and treatment of thromboembolic disorders. Careful monitoring and communication with healthcare providers are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Testoviron Depot 250mg/Ml
Product Brochure
| Strength | 250 mg/ml |
| Pack Size | 1 ml |
| Packaging Size | 1 ml |
| Brand Name | Testoviron Depot |
| Manufacturer | Zydus Cadila |
| Usage/Application | Treatment of Male hypogonadism |
Testoviron Depot 250 mg/mL
Indications:Testoviron Depot, containing testosterone enanthate, is primarily indicated for:
- Hormone replacement therapy in men with low testosterone levels (hypogonadism).
- Conditions associated with testosterone deficiency, such as decreased libido, fatigue, and muscle weakness.
Testosterone enanthate is an anabolic steroid that promotes the development of male secondary sexual characteristics. It works by binding to androgen receptors, leading to an increase in protein synthesis, muscle mass, and overall physical strength.
Dosage and Administration:- Dosage: The typical starting dose is 250 mg administered intramuscularly every 2 to 4 weeks. Specific dosing may vary based on individual needs and physician recommendations.
- Administration: Inject deep intramuscularly, preferably into the gluteal muscle. Rotate injection sites to minimize discomfort.
- Hypersensitivity to testosterone or any components of the formulation.
- Prostate or breast cancer in men.
- Severe liver or kidney disease.
- Pregnancy or breastfeeding.
- Cardiovascular Risks: Monitor for signs of cardiovascular disease, as testosterone therapy can increase the risk of cardiovascular events.
- Hormonal Imbalances: Regularly assess testosterone levels and adjust dosage accordingly to avoid excess testosterone.
- Sleep Apnea: Use with caution in patients with sleep apnea.
- Liver Function: Monitor liver function tests periodically.
Common side effects:
- Acne
- Mood swings
- Increased hair growth (hirsutism)
- Water retention
- Injection site reactions
Serious side effects:
- Severe allergic reactions
- Elevated blood pressure
- Liver dysfunction
- Increased risk of blood clots
Testoviron Depot may interact with medications affecting liver enzymes or hormone levels. Inform healthcare providers of all medications, including over-the-counter drugs and supplements.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:- Advise patients to report any signs of allergic reactions, mood changes, or unusual physical symptoms.
- Emphasize the importance of adhering to the prescribed dosage and schedule.
- Encourage regular follow-up appointments for monitoring testosterone levels and overall health.
Testoviron Depot is an effective option for testosterone replacement therapy, enhancing quality of life for men with low testosterone levels. Ongoing communication with healthcare providers is essential for optimizing treatment and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Rituximab Injection 100 Mg ( Rituxirel 100 Mg )
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 100 mg |
| Packaging Type | Vial |
| Packaging Size | 10 ml |
| Brand | Rituxirel |
| Manufacturer | Reliance Life Sciences |
| Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
Rituximab Injection (Rituxirel 100 mg)
Indications:Rituximab is indicated for:
- Treatment of certain types of non-Hodgkin lymphoma (NHL).
- Chronic lymphocytic leukemia (CLL).
- Granulomatosis with polyangiitis (Wegener’s granulomatosis).
- Microscopic polyangiitis.
- Rheumatoid arthritis (in combination with methotrexate) in adult patients who have had an inadequate response to other therapies.
Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen found on the surface of B cells. It induces B cell depletion through mechanisms including complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and direct apoptosis.
Dosage and Administration:- Dosage: The typical dosing varies based on the condition being treated. For NHL, a common regimen is 375 mg/m² administered as an intravenous infusion. For rheumatoid arthritis, it’s usually 1000 mg on day 1 and day 15, in combination with methotrexate.
- Administration: Administer via slow intravenous infusion. Monitor patients closely during the first infusion for signs of infusion reactions.
- Hypersensitivity to rituximab or any component of the formulation.
- Active severe infections.
- Infusion Reactions: Monitor for infusion-related reactions, especially during the first infusion. Pre-medication with antihistamines and corticosteroids may be required.
- Infections: Rituximab can increase the risk of serious infections, including progressive multifocal leukoencephalopathy (PML).
- Cardiovascular Events: Use with caution in patients with pre-existing cardiovascular conditions.
- Hepatitis B Virus Reactivation: Monitor patients at risk for HBV reactivation.
Common side effects:
- Infusion reactions (fever, chills, rigors, rash)
- Nausea
- Fatigue
- Headache
Serious side effects:
- Severe allergic reactions
- Infections (including PML)
- Cardiac complications
- Hepatitis B virus reactivation
Rituximab may interact with other immunosuppressive agents or medications that increase infection risk. Inform healthcare providers of all medications being taken.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infusion reactions, infections, or unusual symptoms.
- Discuss the importance of adherence to the treatment regimen and attending follow-up appointments.
- Encourage patients to maintain good hygiene and avoid contact with sick individuals.
Rituximab Injection (Rituxirel 100 mg) is an effective treatment option for various hematological malignancies and autoimmune conditions. Continuous communication with healthcare providers is essential for managing side effects and optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Maball 500mg 50ml Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 500 mg |
| Packaging Type | Vial |
| Packaging Size | 50 ml |
| Brand | Maball-RA |
| Manufacturer | Hetero Healthcare Limited |
Maball-RA 500 mg/50 mL Injection
Indications:Maball-RA, which contains rituximab, is primarily indicated for:
- Treatment of rheumatoid arthritis in adult patients, particularly in those who have had an inadequate response to other therapies.
- Treatment of certain types of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
- Granulomatosis with polyangiitis and microscopic polyangiitis.
Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen on B cells. By binding to CD20, it leads to the destruction of these cells through mechanisms such as complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and direct induction of apoptosis.
Dosage and Administration:- Dosage: The typical dose for rheumatoid arthritis is 1000 mg administered as an intravenous infusion, often given in two doses (day 1 and day 15) in combination with methotrexate.
- Administration: Infuse slowly intravenously. Monitor patients closely during the first infusion for potential infusion reactions. Pre-medication with antihistamines and corticosteroids may be recommended.
- Hypersensitivity to rituximab or any component of the formulation.
- Active severe infections.
- Infusion Reactions: Patients should be monitored for infusion-related reactions, especially during the initial infusion. Symptoms may include fever, chills, and rigors.
- Infection Risk: Increased risk of serious infections, including progressive multifocal leukoencephalopathy (PML), should be considered.
- Cardiovascular Events: Caution is advised in patients with a history of cardiovascular disease.
- Hepatitis B Virus Reactivation: Monitor patients who are at risk for hepatitis B reactivation.
Common side effects:
- Infusion-related reactions (fever, chills, rash)
- Nausea
- Fatigue
- Headache
Serious side effects:
- Severe allergic reactions
- Serious infections
- Hepatitis B reactivation
- Cardiac complications
Rituximab may interact with other medications that affect immune function or increase infection risk. It’s important to inform healthcare providers about all current medications.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infusion reactions, infections, or unusual symptoms promptly.
- Discuss the importance of adhering to the prescribed treatment plan and attending regular follow-up appointments.
- Encourage good hygiene practices to minimize infection risk.
Maball-RA 500 mg/50 mL Injection is an effective treatment option for rheumatoid arthritis and certain hematological malignancies. Ongoing communication with healthcare providers is crucial for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Mero 1g Injection
Product Brochure
| Strength | 1 gm |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
| Injectable Form | Sterile Powder |
| Drug Name | Meropenem 1gm |
Mero 1 g Injection (Meropenem)
Indications:Meropenem is indicated for the treatment of:
- Complicated skin and soft tissue infections.
- Complicated intra-abdominal infections.
- Community-acquired pneumonia.
- Hospital-acquired pneumonia, including ventilator-associated pneumonia.
- Meningitis in pediatric patients.
Meropenem is a broad-spectrum carbapenem antibiotic that inhibits bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), leading to bacterial cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many resistant strains.
Dosage and Administration:- Dosage: The usual adult dosage is 1 g administered intravenously every 8 hours. For severe infections, higher doses may be required. Pediatric dosing is typically based on weight.
- Administration: Administer via slow intravenous infusion over 30 minutes. Ensure proper hydration and monitor for any infusion reactions.
- Hypersensitivity to meropenem or any component of the formulation.
- History of severe allergic reactions to beta-lactam antibiotics (e.g., penicillins, cephalosporins).
- Allergic Reactions: Monitor for signs of anaphylaxis; discontinue use if severe allergic reactions occur.
- CNS Effects: Caution in patients with a history of seizures; meropenem may lower the seizure threshold.
- Clostridium difficile: Risk of C. difficile-associated diarrhea; monitor for gastrointestinal symptoms.
Common side effects:
- Nausea
- Diarrhea
- Headache
- Rash
- Injection site reactions (pain, swelling)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Seizures
- Clostridium difficile infection
- Superinfection with resistant organisms
Meropenem may interact with other medications that affect renal function or are also cleared by the kidneys. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Reconstituted solutions should be used immediately or stored refrigerated and used within 24 hours.
Patient Counseling Information:- Advise patients to complete the full course of therapy, even if they feel better.
- Encourage reporting of any severe side effects, especially signs of allergic reactions or gastrointestinal symptoms.
- Emphasize the importance of hydration during treatment.
Mero 1 g Injection (Meropenem) is a vital broad-spectrum antibiotic used for various serious infections. Regular monitoring and communication with healthcare providers are essential to manage potential side effects and optimize treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Mero 250mg Meropenam Injection
Product Brochure
| Strength | 250 mg |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
Mero 250 mg Injection (Meropenem)
Indications:Meropenem is indicated for the treatment of:
- Complicated skin and soft tissue infections.
- Complicated intra-abdominal infections.
- Community-acquired pneumonia.
- Hospital-acquired pneumonia, including ventilator-associated pneumonia.
- Meningitis in pediatric patients.
Meropenem is a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) in bacteria, leading to cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics.
Dosage and Administration:- Dosage: The usual adult dosage is 500 mg to 1 g every 8 hours, depending on the severity of the infection and the patient's renal function. For pediatric patients, dosing is based on weight.
- Administration: Administered by slow intravenous infusion over 30 minutes. Ensure proper hydration and monitor for infusion-related reactions.
- Hypersensitivity to meropenem or any component of the formulation.
- History of severe allergic reactions to beta-lactam antibiotics (e.g., penicillins, cephalosporins).
- Severe Allergic Reactions: Monitor for signs of anaphylaxis; discontinue use if a serious allergic reaction occurs.
- CNS Effects: Caution in patients with a history of seizures; may lower seizure threshold.
- Clostridium difficile: Risk of C. difficile-associated diarrhea; monitor for gastrointestinal symptoms.
Common side effects:
- Nausea and vomiting
- Diarrhea
- Headache
- Rash
- Injection site reactions (pain, swelling)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Seizures
- Clostridium difficile infection
- Superinfection with resistant organisms
Meropenem may interact with other medications that affect renal function or those that are also cleared by the kidneys. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Reconstituted solutions should be used immediately or stored refrigerated and used within 24 hours.
Patient Counseling Information:- Inform patients about the importance of completing the full course of antibiotics, even if they feel better.
- Advise patients to report any severe side effects, particularly signs of allergic reactions or gastrointestinal symptoms.
- Encourage hydration and monitoring for any unusual symptoms during treatment.
Mero 250 mg Injection (Meropenem) is an effective broad-spectrum antibiotic for various serious infections. Regular monitoring and communication with healthcare providers are essential to optimize treatment outcomes and manage potential side effects. Always consult a healthcare professional for personalized medical advice.
Mero 500mg Meropenam Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 500 mg |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
| Injection Site | IV Only |
| Drug Name | Meropenam 500mg |
Mero 500 mg Injection (Meropenem)
Indications: Mero (Meropenem) is primarily indicated for:
- Complicated Intra-abdominal Infections: Such as peritonitis.
- Complicated Skin and Skin Structure Infections: Including diabetic foot infections.
- Pneumonia: Specifically in patients with ventilator-associated pneumonia.
- Bacterial Meningitis: In pediatric patients.
- Febrile Neutropenia: As part of empirical therapy in febrile neutropenic patients.
Mechanism of Action: Meropenem is a broad-spectrum carbapenem antibiotic that works by:
- Inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many resistant strains.
Dosage and Administration:
- Dosage: The typical dosage for adults ranges from 500 mg to 2 g every 8 hours, depending on the severity of the infection and the specific indication. Dosages may vary for pediatric patients.
- Administration: Given as an intravenous infusion or injection. The reconstitution and dilution instructions should be followed according to the manufacturer's guidelines.
Contraindications:
- Hypersensitivity to meropenem or any component of the formulation.
- History of serious allergic reactions to beta-lactam antibiotics (penicillins, cephalosporins).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of anaphylaxis or severe allergic reactions, especially in patients with a history of allergies to beta-lactam antibiotics.
- Seizure Risk: Caution in patients with a history of seizures or central nervous system disorders, as meropenem may increase the risk of seizures in susceptible individuals.
- Renal Function: Adjustments in dosing may be necessary in patients with renal impairment.
Side Effects:
- Common: Nausea, vomiting, diarrhea, headache, and rash.
- Serious: Clostridium difficile-associated diarrhea, allergic reactions, seizures, and renal impairment (rare).
Drug Interactions: Inform healthcare providers about all medications being taken, particularly those affecting renal function or that may increase seizure risk.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) before reconstitution. Once reconstituted, follow specific storage instructions regarding refrigeration and use within a certain time frame.
Patient Counseling Information:
- Emphasize the importance of completing the full course of antibiotics, even if symptoms improve.
- Advise patients to report any unusual symptoms, particularly severe gastrointestinal symptoms or allergic reactions.
Conclusion: Mero (Meropenem) 500 mg Injection is a critical option for treating severe bacterial infections. Close monitoring and professional guidance are essential to ensure safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Amino Acid (8%) Injection (Nirmin Hepa 8% Injection)
Product Brochure
| Application | Human Nutrition |
| Package Size | 500 ml |
| Form | Liquid |
| Concentration | 8% |
| Purity | 8% |
| Packaging Size | 500 ml |
| Country of Origin | Made in India |
| Brand | Nirmin Hepa |
| Manufacturer | Aculife |
| Treatment | Nutritional lacks |
Amino Acid (8%) Injection (Nirmin Hepa 8% Injection)
Indications:Nirmin Hepa 8% Injection is indicated for:
- Nutritional support in patients who are unable to meet their nutritional requirements through oral intake.
- Conditions requiring parenteral nutrition, such as gastrointestinal disorders, severe burns, trauma, or postoperative recovery.
This injection typically contains a blend of essential and non-essential amino acids, providing a balanced source of protein for patients who need nutritional supplementation.
Mechanism of Action:Amino acids are the building blocks of proteins and play crucial roles in various physiological processes, including tissue repair, immune function, and hormone production. The infusion of amino acids helps to maintain nitrogen balance, support anabolism, and promote recovery in patients who are unable to consume adequate nutrition orally.
Dosage and Administration:- Dosage: The dosage of Nirmin Hepa 8% Injection is determined by the patient’s nutritional requirements, clinical condition, and body weight.
- Administration: It is administered intravenously. The infusion rate should be adjusted based on the patient's tolerance and clinical response.
- Known hypersensitivity to any component of the formulation.
- Severe liver dysfunction or metabolic disorders that prevent proper amino acid utilization.
- Fluid Overload: Monitor for signs of fluid overload, especially in patients with heart or kidney issues.
- Electrolyte Imbalance: Regular monitoring of electrolytes is essential, as amino acid infusions can affect electrolyte levels.
- Liver Function: Use cautiously in patients with liver disease, as their ability to metabolize amino acids may be compromised.
Common side effects:
- Nausea
- Vomiting
- Headache
- Local irritation at the injection site
Serious side effects:
- Anaphylactic reactions (rare)
- Hyperammonemia
- Electrolyte imbalances
Amino acid injections may interact with medications affecting fluid and electrolyte balance. Inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Advise patients about the importance of adhering to the prescribed dosage and infusion schedule.
- Discuss potential side effects and the need for regular monitoring of clinical status and laboratory parameters.
- Encourage patients to report any unusual symptoms, such as allergic reactions or significant gastrointestinal distress.
Nirmin Hepa 8% Injection is a valuable option for providing nutritional support to patients who cannot meet their nutritional needs through oral intake. Continuous communication with healthcare providers is essential for managing potential side effects and optimizing patient outcomes. Always consult a healthcare professional for personalized medical advice.
Menogon Menotrophin 75 IU Injection
Product Brochure
| Strength | 75iu |
| Purity | Highly Purified (HP) |
| Formulation | Highly Purified (HP) |
| Dose Strength | 75IU |
| Packaging Type | Vial |
| Manufactured By | Ferring Pharmaceuticals |
| Usage/Application | Female infertility |
| Storage Instruction | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
Menogon Menotrophin 75 IU Injection
Indications:Menogon is indicated for:
- Ovulation induction in women with anovulation or oligo-ovulation, especially in cases like polycystic ovary syndrome (PCOS).
- Stimulation of ovarian follicle development in women undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF).
- Treatment of male hypogonadotropic hypogonadism to stimulate spermatogenesis.
Menogon contains menotropins (FSH and LH), which are gonadotropins essential for reproductive function.
- Follicle-Stimulating Hormone (FSH) promotes the growth and maturation of ovarian follicles.
- Luteinizing Hormone (LH) triggers ovulation and supports the production of progesterone and estrogen.
By providing these hormones, Menogon facilitates the development of eggs in women and supports sperm production in men.
Dosage and Administration:- Dosage: The typical starting dose is 75 IU administered subcutaneously or intramuscularly. Dosage may be adjusted based on the patient's response and specific treatment goals.
- Administration: Usually given once daily, with the exact timing and duration determined by the healthcare provider.
- Hypersensitivity to menotropins or any component of the formulation.
- Primary ovarian insufficiency or uncontrolled thyroid/adrenal dysfunction.
- Tumors of the ovary, uterus, or breast.
- Ovarian Hyperstimulation Syndrome (OHSS): Monitor for signs of OHSS, which can occur with fertility treatments and may lead to serious complications.
- Multiple Pregnancies: Increased risk of multiple pregnancies with fertility treatments.
- Monitoring: Regular monitoring of hormone levels and ultrasound assessments may be necessary to evaluate follicle development.
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Headache
- Abdominal discomfort or bloating
- Mood swings
Serious side effects:
- Ovarian hyperstimulation syndrome (OHSS)
- Allergic reactions
- Thromboembolic events
Menogon may interact with other medications affecting hormone levels. Patients should inform their healthcare providers about all medications they are taking, including hormonal therapies.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection technique and rotation of injection sites.
- Emphasize the importance of attending follow-up appointments for monitoring.
- Discuss potential side effects and when to seek medical attention, especially for signs of OHSS or severe allergic reactions.
Menogon Menotrophin 75 IU Injection is an effective option for treating fertility issues in both women and men. Close adherence to the treatment plan and communication with healthcare providers are essential for achieving the best possible outcomes. Always consult a healthcare professional for personalized medical advice.
Ambilon 50 Liposomal Amphotericin B Injection
Minimum Order Quantity: 10 Box
Product Brochure
| Formulation Type | Liposomal |
| Dosage/Strength | 50 mg |
| Strength | 50 mg vial |
| Brand | Ambilon |
| Composition | Amphotericin B 50mg |
| Manufacturer | Celon Laboratories Ltd |
| Country of Origin | Made in India |
| Treatment | Severe fungal infections |
Ambilon 50 (Liposomal Amphotericin B) Injection
Overview: Ambilon 50 is a formulation of liposomal amphotericin B, an antifungal medication used primarily for the treatment of severe fungal infections.
Indications:
- Invasive Fungal Infections: Used for the treatment of serious systemic fungal infections, including those caused by Aspergillus, Candida, and Cryptococcus species.
- Fungal Infections in Immunocompromised Patients: Particularly effective in patients with neutropenia or those undergoing chemotherapy.
Mechanism of Action: Liposomal amphotericin B binds to ergosterol in fungal cell membranes, disrupting membrane integrity and leading to cell death. The liposomal formulation helps reduce toxicity and improves the drug's pharmacokinetics.
Dosage and Administration:
- Dosage: The specific dosage depends on the type and severity of the infection. A common dose is 3–6 mg/kg body weight per day, but this may vary based on clinical guidelines.
- Administration: Administered intravenously; the infusion rate should be controlled to minimize infusion-related reactions.
Contraindications:
- Hypersensitivity to amphotericin B or any component of the formulation.
- Caution in patients with renal impairment or electrolyte imbalances.
Warnings and Precautions:
- Monitor renal function regularly, as amphotericin B can be nephrotoxic.
- Watch for signs of infusion-related reactions, such as fever, chills, and rigors.
Side Effects:
- Common: Fever, chills, nausea, vomiting, and infusion site reactions.
- Serious: Risk of nephrotoxicity, electrolyte imbalances, and anaphylactic reactions.
Drug Interactions: Use with caution in combination with other nephrotoxic agents, such as aminoglycosides and non-steroidal anti-inflammatory drugs (NSAIDs).
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise reporting any unusual symptoms, especially signs of allergic reactions or kidney issues.
Conclusion: Ambilon 50 (Liposomal Amphotericin B Injection) is an essential antifungal treatment for invasive fungal infections, particularly in immunocompromised patients. Proper administration and monitoring are crucial for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Nicotinamide + Folic Acid + Cyanocobalamin (Vitcofol Injection)
Product Brochure
| Strength | 500 mcg |
| Pack Size | 10 x 1 ml |
| Pack Type | Vial |
| Drug Composition | Nicotinamide (200mg/ml) + Folic Acid (15mg/ml) + Cyanocobalamin (500mcg/ml) |
| Brand Name | Vitcofol |
| Manufacturer | FDC Ltd |
| Usage/Application | Nutritional deficiencies |
| Packaging Size | 10 ml |
Overview: Vitcofol Injection is a combination of vitamins essential for various bodily functions, particularly in supporting metabolic processes, red blood cell formation, and overall health. It is often used to prevent or treat deficiencies.
Ingredients:
- Nicotinamide (Vitamin B3): Supports energy metabolism and helps maintain healthy skin and nerves.
- Folic Acid (Vitamin B9): Crucial for DNA synthesis, cell division, and the formation of red blood cells. It's especially important during pregnancy.
- Cyanocobalamin (Vitamin B12): Necessary for red blood cell production, neurological function, and DNA synthesis.
Indications:
- Vitamin Deficiencies: Used to treat or prevent deficiencies of these vitamins, particularly in individuals with poor dietary intake or absorption issues.
- Anemia: Supports the treatment of certain types of anemia caused by deficiencies in B vitamins.
- Pregnancy: May be indicated to ensure adequate folic acid levels during pregnancy.
Mechanism of Action:
- Each component plays a vital role in metabolic processes. Nicotinamide assists in energy production, folic acid is essential for cellular division, and cyanocobalamin is critical for nerve health and blood formation.
Dosage and Administration:
- Dosage: The specific dosage may vary based on individual needs and the clinical situation. Typically administered as a single injection or as directed by a healthcare provider.
- Administration: Usually administered intramuscularly or intravenously.
Contraindications:
- Hypersensitivity to any of the components or any ingredient in the formulation.
Warnings and Precautions:
- Monitor for allergic reactions.
- Caution in patients with a history of anemia related to other causes.
Side Effects:
- Common: Mild reactions at the injection site, nausea, or gastrointestinal disturbances.
- Serious: Allergic reactions, though rare.
Drug Interactions:
- May interact with certain medications. Always inform healthcare providers of all concurrent medications.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, particularly signs of allergic reactions.
Conclusion: Nicotinamide + Folic Acid + Cyanocobalamin (Vitcofol Injection) is an important combination for supporting vitamin levels and overall health, particularly in individuals at risk of deficiencies. Proper administration and monitoring are essential for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Amino Acids Injection (Sterimino 10% W/V Injection)
Product Brochure
| Application | Human Nutrition |
| Package Size | 500 ml |
| Form | Liquid |
| Concentration | 10% |
| Purity | 10% |
| Packaging Size | 500 ml |
| Brand | Sterimino |
| Manufacturer | linux |
| Treatment | Nutritional inadequacies |
| Composition | AMINOACID (10% W/N) |
Amino Acids Injection (Sterimino 10% W/V Injection)
Indications: Sterimino 10% is primarily used for:
- Parenteral Nutrition: Providing essential amino acids to patients who are unable to obtain adequate nutrition via oral or enteral routes.
- Support During Surgery or Trauma: To promote protein synthesis and prevent muscle wasting.
- Chronic Illness: In conditions that lead to protein loss or increased protein requirements.
Composition: Each 10% w/v solution typically contains a mix of essential and non-essential amino acids, tailored to meet the nutritional needs of patients.
Mechanism of Action: Amino acids are the building blocks of proteins, crucial for various bodily functions, including tissue repair, enzyme production, and hormone synthesis. Administering amino acids intravenously ensures immediate availability for metabolic processes.
Dosage and Administration:
- Dosage: The dosage depends on the individual patient’s requirements, which can vary based on factors like age, weight, and clinical condition. Typically, dosages may range from 1 to 2 grams of amino acids per kilogram of body weight per day.
- Administration: Given as an intravenous infusion. The rate of administration should be adjusted based on the patient’s tolerance and clinical condition.
Contraindications:
- Hypersensitivity to any component of the formulation.
- Severe renal impairment or hepatic coma.
- Inborn errors of amino acid metabolism.
Warnings and Precautions:
- Monitoring: Patients should be closely monitored for fluid balance, electrolytes, and overall nutritional status.
- Renal Function: Caution in patients with renal impairment; dosage adjustments may be necessary.
- Overdose: Excessive amino acid administration can lead to hyperaminoacidemia, which may cause metabolic disturbances.
Side Effects:
- Common: Nausea, vomiting, diarrhea, and injection site reactions.
- Serious: Allergic reactions, fluid overload, and metabolic imbalances.
Drug Interactions: Inform healthcare providers about all medications being taken, especially those that may affect renal function or protein metabolism.
Storage: Store at room temperature (15°C to 25°C / 59°F to 77°F). Protect from light. Do not freeze. Once opened, use as per local guidelines.
Patient Counseling Information:
- Discuss the purpose of the injection and any potential side effects.
- Encourage reporting of any unusual symptoms or reactions during treatment.
Conclusion: Sterimino 10% Amino Acids Injection is a critical component of parenteral nutrition, ensuring patients receive essential nutrients when they cannot eat adequately. Close monitoring and proper administration are key to achieving optimal therapeutic outcomes. Always consult a healthcare professional for personalized medical advice.
Piracetam NOOTROPIL 200mg injection
Minimum Order Quantity: 10 Box
Product Brochure
| Dose/Strength | 200mg |
| Packaging Size | 200mg/15ml |
| Brand | Nootropil |
| Manufactured By | Dr Reddy's Laboratories Ltd |
| Composition | Piracetam 200mg |
| Usage/Application | Alzheimer's disease |
Piracetam (Nootropil) 200 mg Injection
Indications: Piracetam is used for:
- Cognitive Enhancement: To improve cognitive function in conditions such as dementia and cognitive impairment.
- Myoclonus: As an adjunctive therapy in the treatment of myoclonus associated with epilepsy.
- Stroke Rehabilitation: To aid in recovery from stroke or head injury.
Mechanism of Action: Piracetam is a nootropic that enhances neuronal function. It is believed to work by:
- Modulating neurotransmitter activity (especially acetylcholine).
- Improving blood flow and oxygen consumption in the brain.
- Enhancing synaptic plasticity, which is crucial for learning and memory.
Dosage and Administration:
- Dosage: Typically, the initial dose may range from 1.6 to 4.8 g/day, divided into several doses. The specific dosage for injection should be determined by a healthcare professional based on the patient's needs.
- Administration: Administered intravenously or intramuscularly. The injection should be done carefully, typically in a clinical setting.
Contraindications:
- Hypersensitivity to piracetam or any component of the formulation.
- Severe renal impairment (adjustments may be necessary).
- Pregnancy and breastfeeding (use only if the benefits outweigh risks).
Warnings and Precautions:
- Monitoring: Patients should be monitored for potential side effects and therapeutic effectiveness.
- Renal Function: Use with caution in patients with impaired renal function; dosage adjustments may be necessary.
- Behavioral Changes: Monitor for any changes in behavior or mood.
Side Effects:
- Common: Headache, nervousness, insomnia, gastrointestinal disturbances, and dizziness.
- Serious: Rarely, may cause severe allergic reactions or bleeding disorders.
Drug Interactions: Piracetam may interact with anticoagulants and other CNS-active medications. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature, protected from light. Follow specific storage instructions as provided by the manufacturer.
Patient Counseling Information:
- Discuss potential side effects and the importance of reporting any adverse reactions.
- Advise on the need for follow-up appointments to monitor progress and adjust treatment as necessary.
Conclusion: Piracetam (Nootropil) 200 mg Injection is a nootropic agent used for cognitive enhancement and treatment of myoclonus. Proper administration and monitoring are crucial for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Citicoline Injection (Neticol 2 Ml Injection)
Product Brochure
| Strength | 500 mg |
| Combination | Plain |
| Usage | Head Injury |
| Brand | Neticol |
| Prescription/Non prescription | Prescription |
| Manufacturer | neon |
| Country of Origin | Made in India |
| Form | Injection |
| Treatment | Treatment of Head injury |
Citicoline Injection (Neticol 2 mL Injection)
Indications:Neticol is indicated for:
- Treatment of cognitive dysfunctions, including memory impairment and attention deficits.
- Management of stroke or traumatic brain injury to aid in recovery.
- Neuroprotective therapy in conditions such as Alzheimer's disease and other neurodegenerative disorders.
Citicoline is a precursor of phosphatidylcholine, an essential component of cell membranes. It enhances the synthesis of phospholipids, promotes neuronal membrane repair, and supports neurotransmitter synthesis (especially acetylcholine). This leads to improved neuronal function and protection against cellular injury.
Dosage and Administration:- Dosage: The typical dosage for citicoline injection is 1 g (5 mL) daily, which may vary based on the clinical condition and patient response.
- Administration: Administered intravenously or intramuscularly. For intravenous use, it can be diluted in a suitable solution and infused over a specific period, depending on the healthcare provider's recommendations.
- Hypersensitivity to citicoline or any components of the formulation.
- Caution in patients with severe renal or hepatic impairment.
- Hemodynamic Stability: Monitor vital signs, especially in patients with a history of cardiovascular issues.
- Pregnancy and Lactation: Use with caution; consult a healthcare provider before administration.
- Seizure History: Use cautiously in patients with a history of seizures.
Common side effects:
- Headache
- Nausea
- Insomnia
- Gastrointestinal discomfort
Serious side effects:
- Allergic reactions (rare)
- Elevated blood pressure or heart rate
Citicoline generally has a low potential for drug interactions. However, inform healthcare providers of all medications being taken, especially those affecting blood pressure or central nervous system function.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:- Advise patients about the purpose of the injection and what to expect during treatment.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Encourage patients to maintain a healthy lifestyle to support cognitive function, including proper nutrition and mental exercises.
Citicoline Injection (Neticol 2 mL) is an effective neuroprotective agent used to support cognitive function and recovery from neurological injuries. Regular communication with healthcare providers is essential for monitoring effects and optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Fulvestrant Injection (Fulzos 250mg/5ml Injection)
Minimum Order Quantity: 10 Box
Product Brochure
| Strength | 250 mg |
| Packaging Type | Box |
| Volume | 5 ml |
| Manufactured By | Hetero Healthcare Limited |
| Country of Origin | Made in India |
| Brand | Fulzos |
| Composition | Fulvestrant 250 mg Injection |
| Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
| Usage/Application | Breast cancer |
| Prescription/Non prescription | Prescription |
Fulvestrant Injection (Fulzos 250 mg/5 mL Injection)
Indications:Fulvestrant is indicated for:
- The treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women, particularly in those who have progressed on prior endocrine therapy.
Fulvestrant is an estrogen receptor antagonist that works by binding to estrogen receptors in breast tissue, leading to:
- Downregulation of estrogen receptors.
- Inhibition of estrogen-mediated signaling pathways.
- Induction of apoptosis in hormone-sensitive breast cancer cells.
- Dosage: The typical starting dose is 500 mg administered intramuscularly (IM) as two separate injections of 250 mg each on day 0. This is followed by 250 mg IM on days 14 and 28, and then every month thereafter.
- Administration: Administered as an intramuscular injection in the gluteal muscle. Rotate injection sites to minimize discomfort.
- Hypersensitivity to fulvestrant or any component of the formulation.
- Pregnancy and breastfeeding.
- Bone Health: Monitor bone health in patients at risk for osteoporosis or fractures, as fulvestrant does not prevent bone loss.
- Liver Function: Use caution in patients with hepatic impairment, as fulvestrant is metabolized by the liver.
- Tumor Lysis Syndrome: Monitor for signs of tumor lysis syndrome in patients with a high tumor burden.
Common side effects:
- Hot flashes
- Nausea
- Fatigue
- Injection site reactions (pain, swelling)
- Headache
Serious side effects:
- Hepatotoxicity
- Severe allergic reactions
- Thromboembolic events
Fulvestrant may interact with other medications that affect hepatic enzymes. Always inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light and keep out of reach of children.
Patient Counseling Information:- Instruct patients on the proper administration technique and the importance of rotating injection sites.
- Discuss potential side effects, especially the risk of hot flashes and fatigue, and when to seek medical attention.
- Emphasize adherence to follow-up appointments for monitoring treatment effectiveness and any side effects.
Fulvestrant Injection (Fulzos 250 mg/5 mL) is a vital treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer. Regular monitoring and communication with healthcare providers are essential to optimize treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Dextran 40 + Sodium Chloride (Microspan NS 10gm/0.9gm Infusion)
Minimum Order Quantity: 10 Box
Product Brochure
| Strength | 0.9% |
| Pack Size | 500 ml |
| Container Type | Plastic Bottle |
| Brand | Microspan NS |
| Country of Origin | Made in India |
| Packaging Size | 500 ml in 1 bottle |
| Manufacturer | Claris Lifesciences Ltd |
| Composition | Dextran 40 (10gm) + Sodium Chloride (0.9gm) |
| Prescription/Non prescription | Prescription |
Dextran 40 + Sodium Chloride (Microspan NS 10 g/0.9 g Infusion)
Indications: Microspan NS is primarily indicated for:
- Volume Replacement: As a colloid solution to expand plasma volume in cases of shock, severe dehydration, or during surgical procedures.
- Improvement of Microcirculation: In certain clinical situations where enhanced blood flow is beneficial.
Mechanism of Action:
- Dextran 40: A synthetic colloid that increases osmotic pressure and helps maintain plasma volume by drawing fluid into the vascular space.
- Sodium Chloride: A balanced electrolyte that helps maintain osmotic equilibrium and proper fluid balance in the body.
Dosage and Administration:
- Dosage: The exact dosage will depend on the clinical situation and patient response. Typically administered as an intravenous infusion, under the supervision of healthcare professionals.
- Administration: Administered slowly through an intravenous line, with careful monitoring of the patient’s response to treatment.
Contraindications:
- Hypersensitivity to dextran or any component of the formulation.
- Severe renal impairment or anuria.
- Heart failure or fluid overload conditions.
- Active bleeding or coagulopathy.
Warnings and Precautions:
- Monitoring: Close monitoring of fluid balance, kidney function, and vital signs during administration is essential.
- Allergic Reactions: There is a potential risk of anaphylaxis or hypersensitivity reactions; observe for any signs of allergy.
- Electrolyte Imbalance: Monitor for possible electrolyte imbalances, particularly in patients with underlying conditions.
Side Effects:
- Common: Fever, rash, headache, and nausea.
- Serious: Anaphylactic reactions, fluid overload, and renal impairment.
Drug Interactions: Always inform healthcare providers about all medications being taken, as dextran can interact with anticoagulants and other medications affecting coagulation.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the purpose of the infusion and the importance of monitoring.
- Advise patients to report any signs of allergic reactions or unusual symptoms during treatment.
Conclusion: Microspan NS (Dextran 40 + Sodium Chloride) is an effective volume-expanding solution used in various clinical situations. Careful monitoring and professional administration are essential for optimizing treatment outcomes and minimizing risks. Always consult a healthcare professional for personalized medical advice.
Denosumab Olimab 60mg injection
Product Brochure
| Strength | 60 mg |
| Dose/Strength | 60 mg |
| Packaging Type | Prefilled syringe |
| Brand | Olimab |
| Packaging Size | 1.0 ml prefilled syringe |
| Usage/Application | Hospital |
| Form | Liquid |
| Country of Origin | Made in India |
Denosumab Olimab 60 mg Injection
Indications:Denosumab Olimab is primarily indicated for:
- Treatment of osteoporosis in postmenopausal women at high risk of fracture.
- Treatment of osteoporosis in men at high risk of fracture.
- Prevention of skeletal-related events in patients with bone metastases from solid tumors.
- Treatment of giant cell tumor of bone in adults and skeletally mature adolescents.
Denosumab is a monoclonal antibody that inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a key regulator of osteoclast formation, function, and survival. By blocking RANKL, denosumab decreases bone resorption, leading to increased bone mineral density and reduced fracture risk.
Dosage and Administration:- Dosage: The recommended dose for osteoporosis is 60 mg administered subcutaneously every six months. For patients with bone metastases, the dose is typically 120 mg every month.
- Administration: Denosumab is administered via subcutaneous injection into the upper arm, thigh, or abdomen. Proper technique should be followed to minimize injection site reactions.
- Hypersensitivity to denosumab or any component of the formulation.
- Hypocalcemia (low calcium levels).
- Hypocalcemia: Patients should be monitored for signs of hypocalcemia and calcium levels should be corrected prior to starting treatment.
- Infections: Increased risk of serious infections, including skin infections, has been reported.
- Osteonecrosis of the Jaw (ONJ): There is a risk of ONJ, particularly in patients receiving high doses for cancer treatment. Dental examination and preventive dental care are advised before starting therapy.
- Fractures: Discontinuation of denosumab may lead to rapid bone loss and increase the risk of fractures.
Common side effects:
- Injection site reactions (pain, swelling, redness)
- Back pain
- Musculoskeletal pain
- Constipation
Serious side effects:
- Hypocalcemia
- Serious infections
- Osteonecrosis of the jaw (ONJ)
- Atypical femoral fractures
Denosumab may interact with other medications affecting calcium levels or immune function. Inform healthcare providers of all medications being taken.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infection, jaw pain, or unusual thigh or groin pain.
- Discuss the importance of maintaining adequate calcium and vitamin D intake during treatment.
- Encourage regular dental check-ups and good oral hygiene.
Denosumab Olimab 60 mg Injection is an effective treatment for osteoporosis and conditions associated with bone loss. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
B Complex Extract With Vitamin B12 Injection(Optineuron Injection )
Product Brochure
| Methylcobalamin Strength | 2500 mcg/ml |
| Strength | 2500mcg |
| Pack Size | 5 ml |
| Pack Type | Ampoule |
| Brand Name | Optineuron |
| Manufacturer Name | Lupin Ltd |
| Prescription/Non-Prescription | Non-Prescription |
| Country of Origin | Made in India |
| Treatment | Nutritional deficiencies |
| Packaging Size | 3 ml in 1 ampoule |
B Complex Extract with Vitamin B12 Injection (Optineuron Injection)
Indications:Optineuron Injection is indicated for:
- Vitamin B deficiency, including B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B9 (folate), and B12 (cobalamin).
- Conditions related to neurological health, including neuropathies and neurodegenerative disorders.
- Supportive therapy in various metabolic and hematologic disorders.
The B vitamins in this injection play vital roles in energy metabolism, red blood cell formation, and neurological function. They contribute to the synthesis of neurotransmitters and support the overall health of the nervous system.
Dosage and Administration:- Dosage: The recommended dosage is typically 1 to 2 mL administered intramuscularly or intravenously, depending on the clinical condition and patient response.
- Administration: Administered by healthcare professionals, ensuring proper technique to minimize discomfort and risk of infection.
- Hypersensitivity to any components of the formulation.
- Certain contraindications may apply depending on specific patient conditions; consult a healthcare provider.
- Allergic Reactions: Monitor for any signs of allergic reactions, including rash or anaphylaxis.
- Renal Impairment: Use with caution in patients with renal issues, particularly those receiving high doses of Vitamin B12.
Common side effects:
- Injection site reactions (pain, swelling, redness)
- Mild gastrointestinal disturbances (nausea, diarrhea)
- Allergic reactions (rare)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Symptoms of vitamin toxicity with excessive dosing (rare)
B vitamins generally have low interaction potential, but high doses may affect the absorption of certain medications. Always inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Advise patients to report any unusual symptoms or allergic reactions after the injection.
- Discuss the importance of adhering to any prescribed follow-up treatments or dietary recommendations.
- Encourage maintaining a balanced diet rich in B vitamins.
B Complex Extract with Vitamin B12 Injection (Optineuron) is a valuable therapeutic option for managing vitamin B deficiencies and supporting neurological health. Regular monitoring and communication with healthcare providers are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Tosiban 37.5mg Injection
Minimum Order Quantity: 10 Strip
Product Brochure
| Dose | 37.5 mg |
| Packaging Size | 5 ml Injection in 1 vial |
| Composition | Atosiban Acetate 7.5mg/ml |
| Brand | Tosiban |
| Manufacturer | Zuventus Healthcare Ltd |
| Usage/Application | Premature Labor |
Menopur Menotropin I.P. 75 IU Injection
Product Brochure
| Strength | 75iu |
| Purity | Highly Purified (HP) |
| Formulation | Highly Purified (HP) |
| Packaging Size | 5 injections in 1 packet |
| Form | Injection |
| Dose Strength | 75 iu |
| Packaging Type | Box |
| Manufactured By | Ferring |
| Brand | Menopur |
Menopur Menotropin I.P. 75 IU Injection
Indications:Menopur is indicated for:
- Ovulation induction in women with anovulation or oligo-ovulation, typically due to conditions like polycystic ovary syndrome (PCOS).
- Stimulation of ovarian follicle development in women undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF).
- In men, it may be used for the treatment of hypogonadotropic hypogonadism to stimulate spermatogenesis.
Menopur contains menotropins (FSH and LH), which are hormones that play a crucial role in the regulation of the menstrual cycle and ovulation. FSH (follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles, while LH (luteinizing hormone) is involved in triggering ovulation. This combined action promotes the development of eggs in women and supports spermatogenesis in men.
Dosage and Administration:- Dosage: The typical starting dose for women is 75 IU administered subcutaneously or intramuscularly, often adjusted based on individual response and the specific treatment protocol.
- Administration: The injection is usually given once daily, and the specific timing and duration depend on the treatment plan outlined by a healthcare provider.
- Hypersensitivity to menotropins or any component of the formulation.
- Primary ovarian insufficiency.
- Tumors of the ovary, uterus, or breast.
- Uncontrolled thyroid or adrenal dysfunction.
- Ovarian Hyperstimulation Syndrome (OHSS): Monitor for signs of OHSS, a condition characterized by swollen, painful ovaries, which can occur with fertility treatments.
- Multiple Pregnancies: There is an increased risk of multiple pregnancies with the use of fertility medications.
- Monitoring: Regular monitoring of hormone levels and ultrasound examinations may be necessary to assess follicle development.
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Headache
- Abdominal discomfort or bloating
- Mood swings
Serious side effects:
- Ovarian hyperstimulation syndrome (OHSS)
- Allergic reactions
- Thromboembolic events
Menopur may interact with other medications affecting hormone levels. It is important to inform healthcare providers of all medications being taken, including hormonal therapies.
Storage:Store in the refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection technique and site rotation.
- Advise on the importance of attending regular follow-up appointments for monitoring during treatment.
- Discuss potential side effects and when to seek medical attention, particularly for signs of OHSS or severe allergic reactions.
Menopur Menotropin I.P. 75 IU Injection is an effective treatment for fertility-related issues in women and men. Adherence to the prescribed regimen and close communication with healthcare providers are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Edanox 1.5mg injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 1.5 mg |
| Vial Volume | 1.5 ml |
| Pack Type | Single Vial |
| Packaging Size | 20 ml |
| Manufactured By | Neon |
| Country of Origin | Made in India |
| Brand Name | Edanox |
| Injectable Form | Liquid |
| Usage/Application | Hospital |
| Medicine Type | Injection |
Edanox 1.5 mg Injection (Edoxaban)
Indications:Edanox is indicated for:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following initial therapy with a parenteral anticoagulant.
- Prevention of DVT in patients undergoing hip or knee replacement surgery.
Edoxaban is a direct factor Xa inhibitor that prevents thrombin formation and clot development by selectively inhibiting factor Xa in the coagulation cascade. This action effectively reduces the risk of thromboembolic events.
Dosage and Administration:- Dosage: The typical dosage is 1.5 mg administered once daily. Dosing may vary based on the indication and patient renal function.
- Administration: Administered via subcutaneous injection. It can be given without regard to meals.
- Hypersensitivity to edoxaban or any component of the formulation.
- Active bleeding or conditions that increase the risk of bleeding (e.g., recent surgery, trauma).
- Severe renal impairment (creatinine clearance <15 mL/min).
- Bleeding Risk: Increased risk of bleeding; monitor for signs of bleeding, especially in patients with concurrent anticoagulant therapy.
- Renal Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
- Discontinuation: Avoid abrupt discontinuation; it may increase the risk of thrombotic events.
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Mild liver enzyme elevations
Serious side effects:
- Severe bleeding
- Thrombocytopenia (low platelet count)
- Allergic reactions (anaphylaxis)
Edoxaban may interact with other anticoagulants, antiplatelet agents, and drugs that affect liver enzymes. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection techniques and the importance of rotating injection sites.
- Advise patients to report any signs of unusual bleeding or bruising.
- Discuss the importance of regular follow-up appointments for monitoring.
Edanox 1.5 mg Injection (Edoxaban) is an effective anticoagulant used for preventing and treating thromboembolic disorders. Close monitoring and communication with healthcare providers are essential for optimizing treatment outcomes and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Neostigmine(Myostigmin 2.5mg Injection)
Product Brochure
| Strength | 2.5mg |
| Brand | Myostigmin |
| Composition | neostigmine 2.5mg |
| Packaging Size | 5ml |
| Packaging Type | 5*5 ampoule of 5ml |
| Manufacturer | Neon |
| Dose | 2.5mg |
Neostigmine (Myostigmin 2.5 mg Injection)
Indications: Myostigmin (Neostigmine) is primarily indicated for:
- Myasthenia Gravis: To improve muscle strength in patients with this autoimmune neuromuscular disorder.
- Postoperative Urinary Retention: To stimulate bladder function after surgery.
- Reversal of Neuromuscular Blockade: Used in anesthetic practice to reverse the effects of non-depolarizing neuromuscular blockers.
Mechanism of Action: Neostigmine is an acetylcholinesterase inhibitor that works by:
- Preventing the breakdown of acetylcholine at the neuromuscular junction, which increases the concentration of acetylcholine available to stimulate muscle contractions.
- Enhancing communication between nerves and muscles, thereby improving muscle strength.
Dosage and Administration:
- Dosage: The typical dose for myasthenia gravis is 2.5 mg administered subcutaneously or intramuscularly, with adjustments based on individual response. For reversal of neuromuscular blockade, dosages may vary, typically ranging from 0.5 to 2.5 mg administered intravenously.
- Administration: Administered by healthcare professionals, particularly in cases involving the reversal of neuromuscular blockers.
Contraindications:
- Hypersensitivity to neostigmine or any component of the formulation.
- Mechanical intestinal or urinary obstruction.
Warnings and Precautions:
- Cholinergic Crisis: Monitor for signs of cholinergic crisis (e.g., excessive salivation, muscle weakness), which can lead to respiratory failure.
- Cardiovascular Effects: Use with caution in patients with bradycardia or other cardiac conditions, as neostigmine can affect heart rate.
Side Effects:
- Common: Nausea, vomiting, diarrhea, abdominal cramps, increased salivation, and sweating.
- Serious: Severe bradycardia, muscle cramps, or signs of cholinergic crisis.
Drug Interactions: Neostigmine may interact with other medications, especially those affecting neuromuscular transmission or having anticholinergic effects. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:
- Educate patients or caregivers on the importance of adhering to prescribed doses and recognizing signs of cholinergic crisis.
- Advise reporting any unusual symptoms, such as excessive salivation or muscle weakness.
Conclusion: Myostigmin (Neostigmine) 2.5 mg Injection is an effective treatment for managing myasthenia gravis and reversing neuromuscular blockade. Close monitoring and professional administration are essential for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Remicade Infliximab 100 Mg Injection
Product Brochure
| Drug Strength | 100 mg |
| Pack Type | Vial |
| Brand Name | Remicade |
| Manufacturer | Janssen |
| Usages | Rheumatoid arthritis,Ankylosing spondylitis,Psoriasis,Ulcerative colitis,Crohn's disease |
| Shelf Life | 24 months |
| Prescription Type | Non-Prescription |
Remicade (Infliximab) 100 mg Injection
Indications: Remicade (Infliximab) is primarily indicated for:
- Rheumatoid Arthritis: Treatment of adult patients in combination with methotrexate.
- Crohn's Disease: Treatment of adults and pediatric patients with moderate to severe active Crohn's disease.
- Ulcerative Colitis: Treatment of adults with moderate to severe ulcerative colitis.
- Ankylosing Spondylitis: Treatment of adults with active ankylosing spondylitis.
- Psoriatic Arthritis: Treatment of adult patients with active psoriatic arthritis.
- Plaque Psoriasis: Treatment of adults with chronic severe plaque psoriasis.
Mechanism of Action: Infliximab is a monoclonal antibody that works by:
- Binding to tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. This binding prevents TNF-alpha from interacting with its receptors, leading to reduced inflammation and immune response.
Dosage and Administration:
- Dosage:
- The initial dose varies by indication but generally starts with 5 mg/kg administered as an intravenous infusion. Subsequent doses are given at weeks 2 and 6, followed by maintenance doses every 8 weeks.
- Administration: Administered as an intravenous infusion over at least 2 hours. Pre-medication with antihistamines or corticosteroids may be considered to reduce infusion reactions.
Contraindications:
- Hypersensitivity to infliximab or any component of the formulation.
- Moderate to severe heart failure.
- Active infections, including tuberculosis.
Warnings and Precautions:
- Infections: Increased risk of serious infections; patients should be monitored for signs of infection.
- Malignancies: Increased risk of lymphomas and other malignancies in patients receiving TNF inhibitors.
- Hepatitis B Reactivation: Monitor patients for reactivation of hepatitis B virus.
Side Effects:
- Common: Infusion-related reactions (fever, chills, headache), nausea, and fatigue.
- Serious: Serious infections, liver failure, and allergic reactions.
Drug Interactions: Infliximab may interact with other immunosuppressive agents or biologics. Always inform healthcare providers of all medications being taken.
Storage: Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the potential risks, including infections and allergic reactions.
- Advise patients to report any signs of infection, fever, or unusual symptoms promptly.
Conclusion: Remicade (Infliximab) 100 mg Injection is an effective treatment for several autoimmune conditions. Close monitoring for side effects and infections is essential for patient safety. Always consult a healthcare professional for personalized medical advice.
Genevac B Vaccine
Product Brochure
| Pack Size | 1 ml |
| Brand | Genevac-B |
| Composition | Hepatitis B Vaccine |
| Treatment | Prevention of Hepatitis B infection |
| Prescription/Non prescription | Non prescription |
| Form | Injection |
| Shelf life | 24 Month |
| Manufactured By | Serum Institute Of India Ltd |
| Country of Origin | Made in India |
Genevac B Vaccine
Indications: Genevac B is primarily indicated for:
- Hepatitis B Immunization: Prevention of hepatitis B virus infection in individuals at risk, including infants born to infected mothers, healthcare workers, and individuals with multiple sexual partners or chronic liver disease.
Mechanism of Action:
- Genevac B is a recombinant hepatitis B vaccine that works by stimulating the immune system to produce antibodies against the hepatitis B virus (HBV). It contains hepatitis B surface antigens that trigger an immune response without causing the disease.
Dosage and Administration:
- Dosage: The vaccine is typically administered in a series of three doses:
- First dose: at birth or as soon as possible.
- Second dose: 1 month after the first dose.
- Third dose: 6 months after the first dose.
- Administration: Given as an intramuscular injection, usually in the deltoid muscle for adults and older children, or in the anterolateral thigh for infants.
Contraindications:
- Hypersensitivity to any component of the vaccine.
- Moderate or severe acute illness (vaccination should be postponed until recovery).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of anaphylaxis or severe allergic reactions following vaccination.
- Immunocompromised Patients: The vaccine may be less effective in individuals with weakened immune systems.
Side Effects:
- Common: Pain at the injection site, fatigue, headache, and mild fever.
- Serious: Allergic reactions (anaphylaxis), though rare.
Drug Interactions: Genevac B may be administered simultaneously with other vaccines, but different injection sites should be used. Always inform healthcare providers of all medications and vaccines being administered.
Storage: Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the importance of completing the vaccine series for full protection.
- Advise patients to report any unusual symptoms following vaccination.
Conclusion: Genevac B Vaccine is an effective preventive measure against hepatitis B virus infection. Adherence to the vaccination schedule and monitoring for side effects are crucial for optimal protection. Always consult a healthcare professional for personalized medical advice.
Exemptia 40 Mg/0.8ml Injection
Product Brochure
| Strength / Dose | 40 mg / 0.8 ml |
| Manufacturer | Zydus |
| Packaging Type | Pre Filled Syringe |
| Brand | Exemptia |
| Composition | Adalimumab |
| Prescription/Non-Prescription | Prescription |
| Treatment | Ankylosing spondylitis |
Exemptia 40 mg/0.8 mL Injection (Adalimumab)
Indications:Exemptia is indicated for the treatment of:
- Moderate to severe rheumatoid arthritis in adults.
- Moderate to severe juvenile idiopathic arthritis in children aged 2 years and older.
- Psoriasis in adults and children aged 4 years and older.
- Ankylosing spondylitis.
- Crohn's disease and ulcerative colitis.
- Hidradenitis suppurativa.
- Uveitis.
Adalimumab is a monoclonal antibody that selectively binds to tumor necrosis factor-alpha (TNF-α), a cytokine involved in systemic inflammation. By inhibiting TNF-α, Exemptia reduces inflammatory responses and helps manage autoimmune conditions.
Dosage and Administration:- Dosage: The initial dose is usually 40 mg administered subcutaneously, followed by maintenance doses of 40 mg every other week, or as directed by a healthcare provider based on the specific condition and patient response.
- Administration: Administered subcutaneously. Patients may be trained to self-inject after proper instruction from healthcare providers.
- Hypersensitivity to adalimumab or any component of the formulation.
- Active infections, including tuberculosis.
- Severe heart failure.
- Infections: Increased risk of serious infections; monitor for signs of infection before and during treatment.
- Malignancies: Increased risk of certain cancers in patients receiving TNF inhibitors; assess risk factors.
- Neurological Effects: Caution in patients with a history of demyelinating disorders (e.g., multiple sclerosis).
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Headache
- Nausea
- Rash
Serious side effects:
- Serious infections (e.g., tuberculosis, bacterial, viral)
- Allergic reactions (anaphylaxis)
- Liver dysfunction
- Heart failure exacerbation
Adalimumab may interact with other immunosuppressive agents or biologics. Inform healthcare providers of all medications being taken.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light. Allow the injection to reach room temperature before use.
Patient Counseling Information:- Advise patients on how to recognize signs of infection and when to seek medical attention.
- Discuss the importance of regular follow-up appointments to monitor response and any potential side effects.
- Instruct on proper self-injection techniques, if applicable.
Exemptia 40 mg/0.8 mL Injection (Adalimumab) is an effective treatment option for various autoimmune conditions. Regular monitoring and open communication with healthcare providers are essential for safe and effective use. Always consult a healthcare professional for personalized medical advice.
Protamine Sulfate Injection (Neutrahep 10mg Injection)
Product Brochure
| Packaging Type | 5X5 ml Vials |
| Composition | Protamine sulfate 10mg |
| Brand | Neutrahep |
| Manufacturer | Gland Pharma Limited |
| Dose | 10 mg |
| Usage/Application | Heparin glut |
Overview: Protamine sulfate is a medication primarily used to reverse the effects of heparin, an anticoagulant (blood thinner). It is especially important in situations where rapid reversal of heparin is needed, such as during or after surgery.
Indications:
- Heparin Overdose: Used to counteract the effects of heparin in cases of overdose or excessive anticoagulation.
- Surgical Procedures: Administered after procedures involving heparin to restore normal blood clotting.
Mechanism of Action: Protamine sulfate works by binding to heparin to form a stable complex that neutralizes its anticoagulant effects. This reversal allows for the restoration of normal coagulation.
Dosage and Administration:
- Dosage: The dosage depends on the amount of heparin administered and the clinical situation. A typical starting dose may be 1 mg of protamine for every 100 units of heparin, but this should be calculated based on specific circumstances.
- Administration: Given intravenously, typically slowly to avoid adverse reactions.
Contraindications:
- Hypersensitivity to protamine sulfate or any of its components.
- Caution in patients with fish allergies (as protamine is derived from fish sperm) and those with a history of allergic reactions to protamine.
Warnings and Precautions:
- Monitor for allergic reactions, including anaphylaxis.
- Use with caution in patients with a history of bleeding disorders or low platelet counts.
Side Effects:
- Common: Flushing, hypotension, bradycardia, and nausea.
- Serious: Severe allergic reactions and cardiovascular effects.
Drug Interactions:
- May interact with other anticoagulants or medications affecting blood clotting. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture.
Patient Counseling:
- Inform patients about the purpose of the injection and possible side effects.
- Advise them to report any unusual symptoms, particularly signs of allergic reactions.
Conclusion: Protamine Sulfate Injection (Neutrahep 10 mg) is an essential agent for reversing heparin’s anticoagulant effects in critical situations. Proper administration and monitoring are vital for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Ethamsylate Injection (Ethamo 125mg Injection )
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 125 mg |
| Manufacturer | Biochem Pharmaceutical Industries |
| Composition | Ethamsylate 125mg |
| Brand | Ethamo |
| Dose/Strength | 125 mg |
| Pack Size | 2 ml in 1 vial |
| Treatment | Bleeding |
Cerebroprotein Hydrolysate (Cerebrolysin 10ml)
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 215.2mg |
| Packaging Size | 10ml |
| Brand | Cerebrolysin |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Usage/Application | Head injury |
| Composition | Cerebroprotein Hydrolysate 215.2mg |
Cerebroprotein Hydrolysate (Cerebrolysin 10 ml)
Indications: Cerebrolysin is primarily used for:
- Cognitive Disorders: Such as Alzheimer’s disease, vascular dementia, and other neurodegenerative conditions.
- Stroke: To support recovery following acute ischemic strokes.
- Traumatic Brain Injury: As an adjunct therapy in rehabilitation.
- Cerebral Ischemia: To improve cognitive function in patients with compromised brain perfusion.
Mechanism of Action: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain tissue. It is thought to exert neuroprotective effects by:
- Enhancing neuronal survival and regeneration.
- Modulating neurotransmitter systems.
- Improving metabolic processes in neurons and glial cells.
Dosage and Administration:
- Dosage: Typically, the recommended dosage ranges from 5 to 30 ml, depending on the condition being treated. Specific dosing regimens may vary based on individual patient needs and response.
- Administration: Can be administered via intravenous or intramuscular injection. The solution should be used immediately after opening.
Contraindications:
- Hypersensitivity to Cerebrolysin or any of its components.
- Severe renal impairment.
- Pregnancy and breastfeeding (unless deemed necessary by a physician).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of hypersensitivity during administration.
- Renal Function: Use cautiously in patients with impaired renal function.
- Monitoring: Patients should be monitored for any adverse reactions, especially during the initial treatment phase.
Side Effects:
- Common: Mild reactions at the injection site, headache, dizziness, and gastrointestinal disturbances.
- Serious: Allergic reactions (anaphylaxis) and severe hypersensitivity reactions, though these are rare.
Drug Interactions: Cerebrolysin may interact with other medications that affect the central nervous system. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature, protected from light. Once opened, use the solution immediately, and do not freeze.
Patient Counseling Information:
- Instruct patients on the proper administration technique if they are to self-administer.
- Advise reporting any unusual symptoms or side effects promptly.
- Discuss the importance of adhering to follow-up appointments for ongoing evaluation.
Conclusion: Cerebrolysin (Cerebroprotein Hydrolysate) is a therapeutic option for various cognitive and neurological disorders, with a focus on improving recovery and brain function. Close monitoring and professional guidance are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized advice regarding its use.
Potphos Injection Potassium Phosphate 15ml
Minimum Order Quantity: 10 Kg
Product Brochure
| Grade Standard | Bio-Tech Grade |
| Form | Liquid |
| Country of Origin | Made in India |
| Manufacturer | Neon |
| Brand Name | Potphos |
| Composition | Pothesium Phosphates |
| Prescription/Non prescription | Prescription |
| Packaging Size | 15ml |
Potphos Injection (Potassium Phosphate) 15 mL
Overview: Potphos is a sterile injectable solution containing potassium phosphate, used primarily to manage electrolyte imbalances.
Indications:
- Hypokalemia: Treatment of low potassium levels in the blood.
- Phosphate Supplementation: Used in patients who require phosphate for various medical conditions.
- Total Parenteral Nutrition (TPN): As a component in TPN formulations to maintain electrolyte balance.
Mechanism of Action: Potassium phosphate provides both potassium and phosphate ions, essential for various physiological functions, including nerve transmission, muscle contraction, and cellular metabolism.
Dosage and Administration:
- Dosage: The specific dosage will depend on the patient's condition, serum electrolyte levels, and clinical response. Always follow healthcare provider instructions.
- Administration: Administered intravenously. Ensure proper dilution and administration technique to avoid local irritation.
Contraindications:
- Hyperkalemia (high potassium levels).
- Severe renal impairment or conditions where potassium retention is a concern.
Warnings and Precautions:
- Monitor serum potassium and phosphate levels closely during treatment.
- Use caution in patients with renal impairment or those on medications that affect potassium levels.
Side Effects:
- Common: Local irritation at the injection site, gastrointestinal disturbances (e.g., nausea).
- Serious: Risk of hyperkalemia, hypophosphatemia, or adverse cardiac effects due to electrolyte imbalances.
Drug Interactions: Caution with other medications that may affect potassium levels or renal function.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and keep out of reach of children.
Patient Counseling:
- Inform patients about the importance of monitoring electrolyte levels.
- Advise to report any symptoms of electrolyte imbalances, such as muscle weakness or irregular heartbeat.
Conclusion: Potphos Injection (Potassium Phosphate) 15 mL is essential for managing electrolyte imbalances and supporting metabolic functions. Proper administration and monitoring are crucial for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Intravenous Fat Emulsion Infusion (Nirpid 20% Infusion)
Minimum Order Quantity: 10 Vial
Product Brochure
| Packaging Size | 250 ml |
| Brand | Nirpid |
| Composition | Intravenous Fat Emulsion (20% w/v) |
| Country of Origin | Made in India |
| Manufacturer | Aculife |
| Treatment | Provide Calories |
| Strength | 20% w/v |
| Prescription/Non prescription | Prescription |
Nirpid 20% Intravenous Fat Emulsion Infusion
Overview: Nirpid is a 20% intravenous fat emulsion designed to provide essential fatty acids and energy in patients requiring parenteral nutrition.
Indications:
- Total Parenteral Nutrition (TPN): Used as a source of calories and essential fatty acids in patients who cannot consume food orally or enterally.
- Caloric Supplementation: For patients with increased caloric needs due to illness, surgery, or metabolic stress.
Mechanism of Action: Nirpid delivers fatty acids, which are crucial for cellular structure and function. It provides a concentrated source of energy and helps maintain lipid metabolism.
Dosage and Administration:
- Dosage: The specific dosage will depend on the patient’s caloric needs, nutritional status, and clinical condition. Generally, the infusion rate should be adjusted based on tolerance.
- Administration: Administered intravenously; can be given as a continuous infusion or intermittently. Follow proper infusion protocols to minimize the risk of complications.
Contraindications:
- Known hypersensitivity to egg phospholipids, soybean oil, or any components of the emulsion.
- Severe liver disease or severe hyperlipidemia.
Warnings and Precautions:
- Monitor for signs of allergic reactions, particularly in patients with egg allergies.
- Use cautiously in patients with compromised liver function or those at risk for fat overload.
- Regularly monitor lipid levels to prevent hyperlipidemia.
Side Effects:
- Common: Nausea, vomiting, diarrhea, or abdominal discomfort.
- Serious: Risk of fat overload syndrome, pulmonary lipidosis, or allergic reactions.
Drug Interactions: Caution is advised when used with other medications, especially those that may affect lipid metabolism or renal function.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Do not freeze. Keep out of reach of children.
Patient Counseling:
- Inform patients and caregivers about the purpose of the infusion and potential side effects.
- Advise reporting any unusual symptoms, such as allergic reactions or gastrointestinal issues.
Conclusion: Nirpid 20% Intravenous Fat Emulsion Infusion is a vital component of parenteral nutrition, providing essential fats and energy for patients unable to eat normally. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Cytarabine Injection (Arasid 500mg Injection )
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 500 mg |
| Pack Size | 500 mg/5 ml |
| Pack Type | 5 ml in 1 Vial |
| Composition | Cytarabine 500mg |
| Brand Name | Arasid |
| Manufactured by | Intas Pharmaceuticals Ltd |
| Uses/Treatment | Blood cancer |
Cytarabine Injection (Arasid 500 mg Injection)
Indications:Cytarabine is indicated for:
- The treatment of acute myeloid leukemia (AML).
- The treatment of acute lymphoblastic leukemia (ALL).
- The treatment of meningeal leukemia.
- Other hematologic malignancies as determined by a healthcare provider.
Cytarabine is a nucleoside analog that inhibits DNA synthesis and repair. It gets incorporated into the DNA during the S-phase of the cell cycle, leading to the termination of DNA chain elongation and ultimately causing cell death, particularly in rapidly dividing cancer cells.
Dosage and Administration:- Dosage: The dosing regimen varies based on the type of cancer and the treatment protocol. For adults with AML, a common starting dose is 100 mg/m² administered intravenously over a period of 1 to 3 hours, typically in cycles.
- Administration: Can be given intravenously, subcutaneously, or intrathecally (for CNS involvement). Ensure proper hydration and monitor for any infusion-related reactions.
- Hypersensitivity to cytarabine or any component of the formulation.
- Severe bone marrow suppression.
- Bone Marrow Suppression: Regular monitoring of blood counts is essential, as cytarabine can cause leukopenia, thrombocytopenia, and anemia.
- CNS Toxicity: Monitor for signs of CNS toxicity, particularly when given intrathecally, which may include headache, nausea, vomiting, and seizures.
- Gastrointestinal Effects: Cytarabine can cause mucositis and diarrhea; monitor for gastrointestinal symptoms.
Common side effects:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Rash
- Fever
Serious side effects:
- Severe bone marrow suppression
- Hepatotoxicity
- Pulmonary toxicity
- CNS toxicity (when given intrathecally)
Cytarabine may interact with other chemotherapeutic agents and medications that affect bone marrow function. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:- Advise patients on the importance of regular blood tests to monitor blood counts.
- Discuss potential side effects, particularly nausea and risk of infection, and when to seek medical attention.
- Encourage hydration and maintaining a balanced diet during treatment.
Cytarabine Injection (Arasid 500 mg) is an effective chemotherapy agent for various hematologic malignancies. Regular monitoring and communication with healthcare providers are crucial for managing side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Sigrima Pertuzumab 420 Mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 420 mg |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Brand Name | Sigrima |
| Manufacturer | Zydus |
| Shelf Life | 24 Month to 36 Month |
| Storage Condition | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
| Composition | Pertuzumab |
Bortero Bortezomib 2mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Dose/Strength | 2 mg |
| Form | Injection |
| Packaging Type | Vial |
| Manufactured By | Hetero Drugs Ltd |
| Usage/Application | Hospital |
| Shelf life | 36 Month |
| Brand Name | Bortero |
Bortero (Bortezomib) 2 mg Injection
Indications: Bortero (Bortezomib) is primarily indicated for:
- Multiple Myeloma: Treatment of patients with multiple myeloma who have received at least one prior therapy.
- Waldenström’s Macroglobulinemia: As part of a combination therapy in patients with this condition.
Mechanism of Action: Bortezomib is a proteasome inhibitor that works by:
- Inhibiting the proteasome, which leads to the accumulation of regulatory proteins that promote apoptosis (programmed cell death) in cancer cells.
- Disrupting the survival pathways of neoplastic cells, ultimately resulting in reduced tumor growth.
Dosage and Administration:
- Dosage: The typical starting dose is 1.3 mg/m² body surface area, administered as a subcutaneous injection or intravenous infusion. Treatment cycles usually last 21 days, with administration on days 1, 4, 8, and 11 for the first cycle, followed by adjustments based on patient response and side effects.
- Administration: Administered by a healthcare professional with experience in oncology treatments.
Contraindications:
- Hypersensitivity to bortezomib or any component of the formulation.
- Caution in patients with active infections or severe hepatic impairment.
Warnings and Precautions:
- Peripheral Neuropathy: Monitor for signs of peripheral neuropathy, which may occur in some patients.
- Thrombocytopenia: Regular blood count monitoring is essential, as bortezomib can cause low platelet counts.
- Cardiac Events: Caution in patients with a history of cardiac conditions; monitor for heart-related side effects.
Side Effects:
- Common: Nausea, diarrhea, fatigue, peripheral neuropathy, and low blood counts (anemia, thrombocytopenia).
- Serious: Severe allergic reactions, progressive multifocal leukoencephalopathy (PML), and cardiovascular complications.
Drug Interactions: Bortezomib may interact with other medications, particularly those that can affect blood cell counts or have neurotoxic effects. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about potential side effects, particularly the risk of neuropathy and blood count changes.
- Advise patients to report any new or worsening symptoms, including signs of infection or neurological changes.
Conclusion: Bortero (Bortezomib) 2 mg Injection is an effective treatment for multiple myeloma and related conditions. Close monitoring for side effects and professional administration are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Domin Dopamine 200mg injection
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 200 mg |
| Pack Size | 5 ml |
| Packaging Type | Ampoule |
| Form | Injection |
| Brand Name | Domin |
| Composition | Dopamine 200mg |
| Manufacturer | Neon |
Domin (Dopamine) 200 mg Injection
Overview: Domin is an injectable formulation of dopamine, a catecholamine used in medical settings primarily for its effects on cardiovascular function.
Indications:
- Shock: Treatment of hemodynamic support in patients with shock, especially those with low cardiac output or low blood pressure.
- Heart Failure: Used in the management of acute heart failure and to improve renal perfusion in certain cases.
- Bradycardia: May be used to increase heart rate in patients with bradycardia.
Mechanism of Action: Dopamine acts on dopaminergic receptors, as well as alpha and beta-adrenergic receptors, depending on the dose:
- Low doses (1-5 mcg/kg/min): Primarily stimulates dopaminergic receptors, leading to vasodilation and increased renal blood flow.
- Moderate doses (5-10 mcg/kg/min): Stimulates beta-1 adrenergic receptors, increasing heart rate and contractility.
- High doses (>10 mcg/kg/min): Stimulates alpha-adrenergic receptors, causing vasoconstriction and increased blood pressure.
Dosage and Administration:
- Dosage: The initial dosage may vary based on the indication. Typical starting doses range from 1 to 5 mcg/kg/min, adjusted according to patient response.
- Administration: Administered via continuous intravenous infusion, usually requiring dilution in an appropriate intravenous fluid.
Contraindications:
- Hypersensitivity to dopamine or any component of the formulation.
- Patients with pheochromocytoma (a type of tumor that secretes catecholamines).
Warnings and Precautions:
- Monitor blood pressure, heart rate, and cardiac output continuously during administration.
- Use with caution in patients with arrhythmias or myocardial infarction.
Side Effects:
- Common: Nausea, vomiting, palpitations, and headache.
- Serious: Risk of arrhythmias, hypertension, and tissue necrosis with extravasation.
Drug Interactions: Caution is advised when used with other medications that affect cardiovascular function, including other sympathomimetics and certain anesthetics.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients (and their families) about the purpose of the medication and potential side effects.
- Advise to report any unusual symptoms, particularly chest pain, shortness of breath, or severe headache.
Conclusion: Domin (Dopamine) 200 mg Injection is an important medication for providing cardiovascular support in critical situations. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Paracetamol Infusion ( Neomol100ml I.V Infusion )
Minimum Order Quantity: 10 Piece
Product Brochure
| Pack Size | 100 ml |
| Drug Composition | Paracetamol 1000mg |
| Brand | Neomol |
| Manufacturer | Neon Laboratories Ltd |
| Prescription/Non-Prescription | Prescription |
| Treatment | Pain relief |
Overview: Paracetamol (also known as acetaminophen) is a widely used analgesic (pain reliever) and antipyretic (fever reducer). The intravenous formulation allows for rapid administration and is particularly useful in patients who cannot take oral medications.
Indications:
- Pain Relief: Management of mild to moderate pain, such as postoperative pain or pain due to chronic conditions.
- Fever Reduction: Used to lower fever in various medical conditions.
Mechanism of Action: Paracetamol works by inhibiting the synthesis of prostaglandins in the brain, which helps to reduce pain and fever. It primarily acts on the central nervous system, making it effective for systemic relief.
Dosage and Administration:
- Dosage: The typical adult dosage is 1000 mg (10 ml) administered intravenously every 6 hours as needed, not exceeding 4000 mg in 24 hours. Dosing for children and specific populations may vary.
- Administration: The infusion should be administered slowly over 15 minutes to minimize the risk of adverse reactions.
Contraindications:
- Severe liver dysfunction or active liver disease.
- Hypersensitivity to paracetamol or any components of the formulation.
Warnings and Precautions:
- Monitor liver function, especially in patients with pre-existing liver conditions or those consuming alcohol regularly.
- Caution in patients with renal impairment.
Side Effects:
- Common: Injection site reactions (pain, redness, swelling), nausea, and headache.
- Serious: Rare risk of hepatotoxicity, especially with overdose or prolonged use.
Drug Interactions:
- Paracetamol may interact with anticoagulants (e.g., warfarin) and other medications metabolized by the liver. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the infusion and potential side effects.
- Advise them to report any unusual symptoms, particularly signs of allergic reactions or liver dysfunction (e.g., jaundice).
Conclusion: Paracetamol Infusion (Neomol 100 ml) is an effective option for pain and fever management, especially in patients unable to take oral medications. Proper administration and monitoring are essential for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Lobet Labetalol 20mg 4ml Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 20 mg |
| Packaging Size | 4 ml |
| Form | Injection |
| Brand | Lobet |
| Composition | Labetalol 20mg |
| Manufacturer | Samarth Life Science |
| Prescription/Non prescription | Prescription |
| Treatment | Hypertensive crisis |
Overview: Labetalol is a combined alpha and beta-adrenergic blocker used primarily for the management of hypertension. It can effectively lower blood pressure by reducing heart rate and decreasing vascular resistance.
Indications:
- Hypertension: Used for the treatment of acute and chronic hypertension, including hypertensive emergencies.
- Pheochromocytoma: Can be used in managing hypertension associated with this type of tumor.
Mechanism of Action: Labetalol works by blocking both beta-adrenergic receptors (leading to decreased heart rate and contractility) and alpha-1 adrenergic receptors (resulting in vasodilation). This dual action helps lower blood pressure effectively.
Dosage and Administration:
- Dosage: The usual starting dose is 20 mg administered intravenously, which may be followed by additional doses based on blood pressure response. Doses can be increased as needed.
- Administration: Administered intravenously, typically over a period of 2 minutes. Continuous monitoring of blood pressure is recommended.
Contraindications:
- Hypersensitivity to labetalol or any component of the formulation.
- Severe asthma or other chronic obstructive pulmonary disease (COPD).
- Severe bradycardia or heart block.
- Cardiogenic shock.
Warnings and Precautions:
- Monitor for signs of hypotension and bradycardia.
- Use with caution in patients with heart failure, diabetes, or liver impairment.
Side Effects:
- Common: Dizziness, fatigue, nausea, and headache.
- Serious: Hypotension, bradycardia, and possible liver function abnormalities.
Drug Interactions:
- May interact with other antihypertensive medications, leading to additive effects. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, particularly those related to heart function (e.g., dizziness, fainting).
Conclusion: Lobet (Labetalol 20 mg / 4 ml Injection) is an effective treatment option for hypertension, especially in acute settings. Proper administration and monitoring are crucial for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
View More